Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cannabist Company HoldingsCBSTQ -50.00% Debt-to-Equity is -2.92 as of Sep. 2025. The stock has 3 warning signs investors should review. Among 813 Drug Manufacturers companies, Cannabist Company Holdings ranks worse than 123001.11% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Cannabist Company Holdings's Debt-to-Equity or its related term are showing as below:
CBSTQ'
s Debt-to-Equity Range Over the Past 10 Years
Min: -16.67 Med: 0.74 Max: 22.54
Current: -2.92
During the past 7 years, the highest Debt-to-Equity Ratio of Cannabist Company Holdings was 22.54. The lowest was -16.67. And the median was 0.74.
CBSTQ's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.27
vs CBSTQ: -2.92
Cannabist Company Holdings (OTCPK:CBSTQ) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Cannabist Company Holdings Debt-to-Equity Related Terms
Cannabist Company Holdings Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CBSTQ vs OWPC, AYURF, PNXP: Debt-to-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabist Company Holdings Debt-to-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Cannabist Company Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabist Company Holdings (CBSTQ) has a Debt-to-Equity of -2.92 as of Sep. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Cannabist Company Holdings and its competitors. According to the industry distribution chart, Cannabist Company Holdings ranks #999999 out of 813 companies in the Drug Manufacturers industry.
Is Cannabist Company Holdings' Debt-to-Equity too high?
Cannabist Company Holdings' current Debt-to-Equity is -2.92. Based on the distribution chart, Cannabist Company Holdings ranks #999999 out of 813 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cannabist Company Holdings' Debt-to-Equity compare to OWPC and AYURF?
According to the Drug Manufacturers industry distribution chart, Cannabist Company Holdings ranks #999999 out of 813 companies for Debt-to-Equity. This places Cannabist Company Holdings in the lower half of its industry. The industry median Debt-to-Equity is 0.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Drug Manufacturers company?
The median Debt-to-Equity among Drug Manufacturers companies is 0.27, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Cannabist Company Holdings and its competitors. For the Drug Manufacturers industry, the median Debt-to-Equity is 0.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabist Company Holdings's current Debt-to-Equity is -2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabist Company Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cannabist Company Holdings (CBSTQ) is currently considered Possible Value Trap. The stock's GF Value™ is $0.15, compared to a current price of $0.00 — trading 99.9% below its estimated fair value. The current Debt-to-Equity is -2.92. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Cannabist Company Holdings (CBSTQ), the current Debt-to-Equity is -2.92 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBSTQ has been successfully added to your 
